Valuation: Original Source Entertainment Inc

Market Cap 12.11M 10.63M 10.04M 9.15M 17.12M 1.16B 17.24M 120M 46.52M 593M 45.47M 44.49M 1.91B P/E 2026 *
-1.81x
P/E 2027 * -2.1x
Enterprise Value 12.11M 10.63M 10.04M 9.15M 17.12M 1.16B 17.24M 120M 46.52M 593M 45.47M 44.49M 1.91B EV / Sales 2026 *
1.27x
EV / Sales 2027 * 0.91x
Free-Float
74.41%
Yield 2026 *
-
Yield 2027 * -
09-17 Neuroone Medical Technologies Corporation Expands U.S. Commercialization of Fda-Cleared Onerf Trigeminal Nerve Ablation System with New Southern California Distribution Agreement CI
08-27 NeuroOne Medical Technologies Corporation Reports Successful Large-Animal Procedures Using Next-Generation StereoCED Platform CI
08-14 NeuroOne Medical Technologies Corporation, Q3 2026 Earnings Call, Aug 13, 2026
08-13 NeuroOne Medical Technologies Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026 CI
08-13 Neuroone Medical Technologies Corporation Provides Revenue Guidance for the Fiscal Year 2026 CI
07-28 NeuroOne Medical Technologies Highlights Potential Paradigm Shift for Patients Treated with the Onerf Brain Ablation System CI
07-16 NeuroOne Medical Technologies Corporation and Mayo Clinic Expand Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial CI
06-29 NeuroOne Medical Technologies Corporation(NasdaqCM:NMTC) added to Russell 3000E Growth Benchmark CI
06-29 NeuroOne Medical Technologies Corporation(NasdaqCM:NMTC) added to Russell 3000E Index CI
06-29 NeuroOne Medical Technologies Corporation(NasdaqCM:NMTC) added to Russell Microcap Index CI
06-29 NeuroOne Medical Technologies Corporation(NasdaqCM:NMTC) added to Russell Microcap Growth Benchmark Index CI
05-23 NeuroOne Medical Technologies Corporation Reaffirms Product Revenue Guidance for the Fiscal Year 2026 CI
05-23 Neuroone Medical Technologies Corporation Announces Restatement of Financial Results for the Quarter Ended March 31, 2026 CI
Manager TitleAgeSince
Corporate Officer/Principal 59 01/02/2019
Chief Executive Officer 61 20/07/2017
Director of Finance/CFO 55 01/07/2026
Director TitleAgeSince
Chairman 70 04/08/2017
Director/Board Member 65 04/08/2017
Director/Board Member 61 20/07/2017
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 12.11M
-2.64%+4.45%+31.82%-18.21% 18.3B
-5.20%-1.82%-39.80%+24.69% 1.85B
0.00%+0.41%-30.18%+23.60% 868M
-0.11%-0.22%+54.26%-2.74% 778M
+2.34%+3.01%-58.77%-84.71% 750M
-0.69%+7.10%-29.65%-47.29% 686M
+1.77%+6.49%-38.67%-52.83% 590M
-0.69%+8.64%+39.17%+89.09% 473M
+5.05%+7.11%-0.46%+9.25% 420M
Average -0.02%+3.91%-8.03%-6.57% 2.75B
Weighted average by Cap. -2.18%+3.90%+18.44%-14.18%

Financials

2026 *2027 *
Net sales 9.54M 8.37M 7.9M 7.2M 13.48M 914M 13.58M 94.57M 36.63M 467M 35.8M 35.03M 1.5B 13.33M 11.69M 11.04M 10.07M 18.84M 1.28B 18.98M 132M 51.19M 653M 50.04M 48.96M 2.1B
Net income -7.8M -6.85M -6.47M -5.89M -11.03M -748M -11.11M -77.4M -29.98M -382M -29.3M -28.67M -1.23B -6.76M -5.93M -5.6M -5.1M -9.56M -648M -9.62M -67.03M -25.96M -331M -25.38M -24.83M -1.06B
Net Debt - -
Logo Original Source Entertainment Inc
NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-